Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlpha Tau Medical LTD.
About this trial
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors
Eligibility criteria
Qualifiers
SCC
BCC
Lentigo maligna melanoma (Dubreuilh melanoma)
Carcinosarcoma
Disqualifiers
Keratoacanthoma
Merkel cell carcinoma
Sarcoma other than carcinosarcoma
Metastatic disease (according to the TNM staging system - M1 patients are excluded)
Trial design
Treatments tested in this trial
- DaRT- Diffusing Alpha-emitters Radiation Therapy
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov